Premium Information is available for this item - Upgrade for $1 a day

6505-01-548-8399

Rosiglitazon Maleate-Metformin

6505015488399 015488399 NDC 0007-3167-18 AVANDAMET

INC: 77777

6505-01-548-8399 ROSIGLITAZON MALEATE-METFORMIN 6505015488399 015488399

Managed by United States
NSN Created on 6 Mar 2007
Data Last Changed
June 2023
NATO Update Count
2
NATO Data Quality
6505-01-548-8399 ROSIGLITAZON MALEATE-METFORMIN 6505015488399 015488399 1/1
NSN 6505-01-548-8399 (Generic Image) 1/1

6505-01-548-8399 Stock and Availability Marketplace 6505-01-548-8399

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-548-8399 RQST NE eBay
eBay Updated Every Day
6505-01-548-8399 RQST eBay
Amazon Updated Every Day
6505-01-548-8399 RQST NE Amazon

6505-01-548-8399 Related Documents Related Documents 6505-01-548-8399 5+ Documents (More...)

NDC 0007-3167-18 AVANDAMET Managed by United States NSN Created on 6 Mar 2007 Data Last Changed June
6505-01-548-8399 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-8399
Rosiglitazon Maleate-Metformin 6505015488399 Maleate Tablets6505995512814 995512814 AVANDAMET https
6505995512814 your web browser . 6505-99-551-2814Rosiglitazone Maleate Tablets6505995512814 995512814 AVANDAMET
2/1000 3103181 0449S-002 A10B D03 uk 6505-99-666-3191 Rosiglitazone/Metfo 6505996663191996663191 AVANDAMET
68024D03-MIL H110-03-31-DZ 86101 An electrical https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-8399
Rosiglitazone Maleate Tablets 6505995512814 2814Rosiglitazone Maleate Tablets6505995512814 995512814 AVANDAMET
6505-99-926-3670Nateglinide Tablets6505999263670 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-8399
Rosiglitazon Maleate-Metformin 6505015488399 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-
JavaScript in your web browser . 6505-99-551-2814Rosiglitazone Maleate Tablets6505995512814 995512814 AVANDAMET
enable JavaScript in your web browser . 6505-99-666-3191Rosiglitazone/Metfo6505996663191 996663191 AVANDAMET
2814Rosiglitazone Maleate Tablets6505995512814 995512814 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-8399
enable JavaScript in your web browser . 6505-99-666-3191Rosiglitazone/Metfo6505996663191 996663191 AVANDAMET
www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-666-3191 Rosiglitazone/Metfo 6505996663191996663191 AVANDAMET
contacts, /258/006 A10B D03 6505-99-551-2814Rosiglitazone Maleate Tablets6505995512814 995512814 AVANDAMET

6505-01-548-8399 Demil Restrictions 6505-01-548-8399

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: A | EDC: A | ADPEC: 0

6505-01-548-8399 is a Rosiglitazon Maleate-Metformin that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6505-01-548-8399 End Users End Users 6505-01-548-8399

Turkey (ZW01)
Effective Date:
1 Mar 2007

6505-01-548-8399 Manufacturers Approved Sources 6505-01-548-8399

6505-01-548-8399 Technical Data Datasheet 6505-01-548-8399

Characteristic
Specifications
FIIG
A23900
Special Features [FEAT]
Avandamet 2Mg/500Mg; Contains 2 Oral Antihyperglycemic Drugs; Manages Type 2 Diabetes; Increases Insulin Sensitivity; Bottle Of 60

6505-01-548-8399 Similar Items Similar Supply Items to 6505-01-548-8399

6505-01-548-8399 Freight Data Freight Information 6505-01-548-8399

6505-01-548-8399 has freight characteristics managed by Turkey.. 6505-01-548-8399 has a variance between NMFC and UFC when transported by rail and the description should be consulted.